Drug:
Reaction: HYPERSENSITIVITY
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26902603 |
US |
2 | |
Hypersensitivity, Urticaria, Oropharyngeal pain, Respiratory disorder, Pruritus, Paranasal sinus discomfort, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 402 | 26891970 |
CA |
43 | 2 |
Epilepsy, Hypoaesthesia, Gait disturbance, Dry mouth, Gastrooesophageal reflux disease, Fatigue, Headache, Hypercholesterolaemia, Folliculitis, Drug hypersensitivity, Grip strength decreased, Facet joint syndrome, Hypertension, Hypersensitivity, Hepatic enzyme increased, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 403 | 26892007 |
US |
43 | 2 |
Depression, Hypersensitivity, Skin laceration, |
||||
LEVETIRACETAM, LACOSAMIDE, TOPIRAMATE, |
||||
| 404 | 26892141 |
CN |
61 | 1 |
Hypersensitivity, |
||||
OBINUTUZUMAB, |
||||
| 405 | 26892371 |
US |
1 | |
Hypersensitivity, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 406 | 26892444 |
|||
Hip fracture, Arthralgia, Chills, Hypersensitivity, Malaise, Tremor, Asthenia, Loss of personal independence in daily activities, Weight decreased, Eye discharge, Heart rate decreased, General physical health deterioration, Thyroid disorder, Condition aggravated, Temperature intolerance, Nervousness, Fatigue, |
||||
AMIODARONE HYDROCHLORIDE, |
||||
| 407 | 26893235 |
CO |
66 | 2 |
Hypoxia, Erythema, Pain in extremity, Hypersensitivity, Paraesthesia, Pruritus, |
||||
IBRUTINIB, IBRUTINIB, |
||||
| 408 | 26893762 |
US |
2 | |
Hypersensitivity, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 409 | 26893831 |
US |
2 | |
Dyspnoea, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 410 | 26894019 |
US |
60 | |
Hypersensitivity, Hypoaesthesia oral, Erythema, Skin reaction, Off label use, |
||||
CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM, ERGOCALCIFEROL, FOLIC ACID, MONTELUKAST, METHYLPHENIDATE HYDROCHLORIDE, OLMESARTAN MEDOXOMIL, LEVOCETIRIZINE DIHYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PANTOPRAZOLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 411 | 26894177 |
US |
1 | |
Conjunctivitis allergic, Hypersensitivity, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TADALAFIL, FLUTICASONE PROPIONATE, GABAPENTIN, SUMATRIPTAN SUCCINATE, |
||||
| 412 | 26894889 |
81 | ||
Urosepsis, Fungal infection, Hypersensitivity, |
||||
DAPAGLIFLOZIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 413 | 26895064 |
US |
||
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 414 | 26895237 |
US |
69 | |
Hypersensitivity, Rash, Urticaria, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 415 | 26895291 |
GB |
||
Lower respiratory tract infection, Dry skin, Skin wound, Skin discharge, Hypersensitivity, Inappropriate schedule of product administration, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 416 | 26895413 |
US |
2 | |
Dermatitis atopic, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 417 | 26895687 |
BR |
51 | 2 |
Pain, Insomnia, Drug interaction, Hypoaesthesia, Hyperhidrosis, Palpitations, Anxiety, Hypersensitivity, Erythema, Tinnitus, Head discomfort, Psychomotor retardation, Therapeutic response unexpected, |
||||
RAVULIZUMAB, RAVULIZUMAB, |
||||
| 418 | 26895812 |
US |
2 | |
Stress, Hypersensitivity, Rash, |
||||
DUPILUMAB, |
||||
| 419 | 26895880 |
EU |
68 | 2 |
Rash, Hypersensitivity, Pruritus, |
||||
GABAPENTIN, GABAPENTIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ENOXAPARIN SODIUM, QUETIAPINE, |
||||
| 420 | 26896137 |
US |
69 | 2 |
Colectomy, Lung disorder, Enteritis, Nausea, Hypersensitivity, |
||||
DUPILUMAB, TREPROSTINIL, MACITENTAN, |
||||
| 421 | 26896141 |
US |
72 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 422 | 26896278 |
CA |
43 | 2 |
Epilepsy, Hypoaesthesia, Gait disturbance, Dry mouth, Gastrooesophageal reflux disease, Fatigue, Headache, Hypercholesterolaemia, Folliculitis, Drug hypersensitivity, Grip strength decreased, Facet joint syndrome, Hypertension, Hypersensitivity, Hepatic enzyme increased, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 423 | 26896286 |
EU |
82 | 2 |
IgG deficiency, Neutrophil count decreased, Hypertension, Bronchitis, Hypersensitivity, |
||||
| 424 | 26896346 |
US |
76 | 1 |
Needle issue, Hypersensitivity, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 425 | 26896371 |
CA |
34 | 2 |
Angina unstable, Hypertension, Gait inability, Hyperhidrosis, Hypersensitivity, Pharyngeal swelling, Swollen tongue, Asthenia, Myocardial infarction, General physical health deterioration, Pain, Malaise, Feeling abnormal, Swelling face, Lymphadenopathy, Dysstasia, Pyrexia, Insomnia, Chest pain, Dizziness, Tremor, Abdominal discomfort, Weight decreased, Circadian rhythm sleep disorder, Rhinitis allergic, Influenza, Menstruation irregular, Immune system disorder, Obstructive airways disorder, Heart rate increased, Pneumonitis, Haemorrhoids, Respiratory disorder, Diarrhoea, Dysmenorrhoea, Cough, Joint swelling, Nasopharyngitis, Rash, Somnolence, Urticaria, Asthma, Dyspnoea, Speech disorder, Cardiac failure, Swelling, Product dose omission issue, Incorrect dose administered, Hypertension, Inappropriate schedule of product administration, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, IPRATROPIUM BROMIDE, |
||||
| 426 | 26896742 |
41 | 2 | |
Angioedema, Drug ineffective, Drug intolerance, Dysphonia, Headache, Hypersensitivity, Swelling face, Swollen tongue, Product ineffective for unapproved use, Off label use, |
||||
RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, |
||||
| 427 | 26896770 |
EG |
27 | 2 |
Spinal osteoarthritis, Hypersensitivity, Prescribed underdose, Multiple sclerosis relapse, |
||||
NATALIZUMAB, |
||||
| 428 | 26896888 |
PK |
52 | 1 |
Hypersensitivity, Urticaria, Dyspnoea, Tachycardia, Palpitations, Psoriasis, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 429 | 26896950 |
US |
2 | |
Hospitalisation, Aortic stenosis, Lymphoma, Salivary gland cancer, Lip dry, Weight decreased, Swelling face, Onycholysis, Fungal skin infection, Dry mouth, Insomnia, Aspartate aminotransferase abnormal, Alanine aminotransferase abnormal, Erythema, Hypersensitivity, Alopecia, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, ORAL SEMAGLUTIDE, |
||||
| 430 | 26896972 |
1 | ||
Pyrexia, Periorbital swelling, Hypersensitivity, Vomiting, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 431 | 26897019 |
2 | ||
Feeling abnormal, Sinusitis, Hypersensitivity, |
||||
| 432 | 26897042 |
US |
70 | 2 |
Hypersensitivity, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 433 | 26897065 |
AU |
66 | 1 |
Anaphylactic reaction, Hypersensitivity, Ventricular fibrillation, Pulseless electrical activity, Left ventricular dysfunction, |
||||
ROCURONIUM BROMIDE, CEFAZOLIN SODIUM, CEFAZOLIN, |
||||
| 434 | 26897135 |
US |
13 | 2 |
Hypersensitivity, Sinusitis, Nasopharyngitis, |
||||
SEBETRALSTAT, GARADACIMAB, ECALLANTIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 435 | 26897251 |
US |
50 | 2 |
Anaphylactic shock, Hypersensitivity, Product use issue, |
||||
TIRZEPATIDE, |
||||
| 436 | 26897261 |
PH |
2 | |
Hypersensitivity, Injection site pruritus, |
||||
TIRZEPATIDE, |
||||
| 437 | 26897352 |
US |
29 | 2 |
Hypersensitivity, |
||||
MIRIKIZUMAB-MRKZ, |
||||
| 438 | 26897411 |
CH |
2 | |
Hospitalisation, Hypersensitivity, Infusion related reaction, |
||||
AMIVANTAMAB-VMJW, |
||||
| 439 | 26897527 |
US |
37 | 2 |
Hypersensitivity, Product dose omission issue, |
||||
DEUCRAVACITINIB, |
||||
| 440 | 26886891 |
US |
2 | |
Hypersensitivity, |
||||
REMIBRUTINIB, |
||||
| 441 | 26887007 |
US |
||
Anaphylactic reaction, Hypersensitivity, Eye swelling, Blister, Eosinophilic oesophagitis, Oropharyngeal pain, |
||||
EPTINEZUMAB-JJMR, |
||||
| 442 | 26887137 |
US |
47 | 2 |
Hypersensitivity, Cardiac failure, |
||||
SELEXIPAG, SELEXIPAG, SELEXIPAG, MACITENTAN, TADALAFIL, TADALAFIL, |
||||
| 443 | 26887161 |
TH |
54 | 2 |
Erythema, Chest discomfort, Hypersensitivity, |
||||
AMIVANTAMAB-VMJW, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 444 | 26887626 |
US |
59 | 1 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 445 | 26887865 |
CO |
55 | 1 |
Depression, Hypersensitivity, Drug ineffective, |
||||
OCRELIZUMAB, |
||||
| 446 | 26887915 |
US |
11 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 447 | 26888091 |
EU |
||
Hepatotoxicity, Pancreatitis, Pneumonitis, Lupus-like syndrome, Multiple sclerosis, Thyroid cancer, Colorectal cancer, Treatment failure, Psoriasis, Alopecia, Off label use, Hypersensitivity, Herpes zoster, |
||||
INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 448 | 26888094 |
US |
62 | 1 |
Hypersensitivity, Blood potassium increased, |
||||
VEDOLIZUMAB, LISINOPRIL, |
||||
| 449 | 26888112 |
US |
55 | 2 |
Injection site swelling, Hypersensitivity, Injection site erythema, Injection site pain, Contusion, Needle issue, |
||||
ORAL SEMAGLUTIDE, FUROSEMIDE, |
||||
| 450 | 26888144 |
US |
60 | 2 |
Hypersensitivity, Rheumatoid arthritis, |
||||
ABATACEPT, |
||||
| 451 | 26888291 |
EU |
58 | 2 |
Nausea, Hypotension, Pallor, Hypersensitivity, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 452 | 26888294 |
CA |
40 | 2 |
Alopecia, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Depression, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fall, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Lip dry, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle spasms, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Synovitis, Systemic lupus erythematosus, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, INFLIXIMAB, INFLIXIMAB, APREMILAST, SECUKINUMAB, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 453 | 26888376 |
US |
58 | |
Protein urine present, Hypersensitivity, Hypogeusia, Hyposmia, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 454 | 26888393 |
CN |
||
Myelosuppression, Hypersensitivity, Cardiotoxicity, Neurotoxicity, Myalgia, Arthralgia, Nausea, Vomiting, Diarrhoea, Respiratory disorder, Skin reaction, Hepatic function abnormal, Renal impairment, |
||||
TRASTUZUMAB, TRASTUZUMAB, |
||||
| 455 | 26888536 |
GB |
81 | 1 |
Urosepsis, Hypersensitivity, Fungal infection, |
||||
DAPAGLIFLOZIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LANSOPRAZOLE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, BISOPROLOL FUMARATE, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, |
||||
| 456 | 26888781 |
US |
27 | 2 |
Paranoia, Periorbital swelling, Rhinorrhoea, Fatigue, Hypersensitivity, Product quality issue, Therapeutic product effect variable, Product physical issue, Drug ineffective, |
||||
AMPHETAMINE, AMPHETAMINE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS, |
||||
| 457 | 26889327 |
US |
30 | 2 |
Hypersensitivity, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 458 | 26889452 |
US |
83 | 2 |
Hypersensitivity, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 459 | 26889563 |
US |
75 | |
Dyspnoea, Hypersensitivity, |
||||
TREPROSTINIL, TIOTROPIUM BROMIDE INHALATION SPRAY, VITAMIN C, MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, BUMETANIDE, TADALAFIL, FLUTICASONE PROPIONATE AND SALMETEROL, ROSUVASTATIN CALCIUM, LOTEPREDNOL ETABONATE, SPIRONOLACTONE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ALBUTEROL SULFATE, COLCHICINE, OXYGEN, 0XYGEN, BECLOMETHASONE DIPROPIONATE HFA, |
||||
| 460 | 26889763 |
US |
80 | 1 |
Hypersensitivity, Eye pruritus, Abnormal sensation in eye, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 461 | 26889950 |
US |
76 | |
Hypersensitivity, |
||||
TREPROSTINIL, TEZEPELUMAB-EKKO, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMLODIPINE BESYLATE, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, BRINZOLAMIDE/BRIMONIDINE TARTRATE, ALBUTEROL SULFATE, NINTEDANIB, LISINOPRIL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, IRON, OXYGEN, 0XYGEN, TEMAZEPAM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, GABAPENTIN, BIMATOPROST, |
||||
| 462 | 26889976 |
US |
76 | 2 |
Ill-defined disorder, Hypersensitivity, Road traffic accident, |
||||
TOCILIZUMAB, TOCILIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ZOLEDRONIC ACID, |
||||
| 463 | 26890030 |
|||
Hypersensitivity, Hypertension, |
||||
NINTEDANIB, |
||||
| 464 | 26890042 |
EU |
31 | 2 |
Hypersensitivity, Injection site erythema, |
||||
NATALIZUMAB, |
||||
| 465 | 26890208 |
EU |
2 | |
Pulmonary embolism, Hypersensitivity, |
||||
EFGARTIGIMOD ALFA, |
||||
| 466 | 26890219 |
US |
81 | 2 |
Hypersensitivity, Rash pruritic, Skin irritation, Sleep disorder, |
||||
INCLISIRAN, |
||||
| 467 | 26890454 |
CA |
23 | 2 |
Hypersensitivity, Pain, Symptom masked, Condition aggravated, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 468 | 26890549 |
CR |
63 | 2 |
Leukopenia, Erythema, Vitiligo, Depression, Anaemia, Nail disorder, Haematocrit decreased, Neutrophil count decreased, Lymphocyte percentage increased, Basophil percentage increased, Mean platelet volume increased, Monocyte percentage increased, Granulocytes abnormal, White blood cell count decreased, Blood bilirubin unconjugated decreased, Neutrophil percentage decreased, Bilirubin conjugated decreased, Mean cell haemoglobin increased, Blood bilirubin increased, Mean cell haemoglobin concentration increased, Pain, Hypersensitivity, Pruritus, Skin disorder, Dry skin, Alopecia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, CALCIUM, IRBESARTAN, LORATADINE, LORATADINE ORAL, |
||||
| 469 | 26890819 |
US |
47 | |
Pneumonia, Impaired gastric emptying, Neuropathy peripheral, Vision blurred, Heart rate increased, Illness, Bronchitis, Productive cough, Influenza like illness, Dehydration, Decreased appetite, Fluid retention, Myalgia, Spinal pain, Anxiety, Blood pressure abnormal, Product dose omission issue, Malnutrition, Malaise, Blood potassium decreased, Cough, Throat irritation, Chest discomfort, Dyspnoea, Flushing, Hypersensitivity, Palpitations, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, DULOXETINE HYDROCHLORIDE, DULOXETINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LEVOCETIRIZINE DIHYDROCHLORIDE, LANSOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, INSULIN GLARGINE, MAGNESIUM, BUPROPION, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ALBUTEROL SULFATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SPIRONOLACTONE, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LOSARTAN POTASSIUM, LOSARTAN, INSULIN LISPRO, BIOTIN, |
||||
| 470 | 26890840 |
US |
2 | |
Swelling face, Rash, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 471 | 26891005 |
EU |
66 | 1 |
Hypersensitivity, |
||||
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE, IOHEXOL, IOHEXOL, IOHEXOL, IOHEXOL, |
||||
| 472 | 26891400 |
US |
1 | |
Hypoaesthesia, Hypersensitivity, Joint swelling, |
||||
ADALIMUMAB, |
||||
| 473 | 26891576 |
US |
2 | |
Peripheral swelling, Illness, Nausea, Erythema, Hypersensitivity, |
||||
RIVAROXABAN, RIVAROXABAN, |
||||
| 474 | 26891677 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, Coeliac disease, Condition aggravated, Drug-induced liver injury, Dyspepsia, Exposure during pregnancy, Fatigue, Drug intolerance, Insomnia, Gastrointestinal disorder, Joint swelling, Hypertension, General physical health deterioration, Nail disorder, Grip strength decreased, Glossodynia, Live birth, Headache, Musculoskeletal stiffness, Malaise, Hypersensitivity, Hand deformity, Hepatic enzyme increased, Product label confusion, Injection site reaction, Infusion related reaction, Nausea, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Wound, Maternal exposure during pregnancy, Adverse reaction, Back injury, Off label use, Normal newborn, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, APREMILAST, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FOLIC ACID, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 475 | 26891851 |
EU |
1 | |
Plasma cell myeloma, Hypersensitivity, |
||||
DEXAMETHASONE SODIUM PHOSPHATE, DARATUMUMAB, LENALIDOMIDE, BORTEZOMIB, |
||||
| 476 | 26881435 |
US |
16 | 1 |
Nasal congestion, Nasopharyngitis, Hypersensitivity, |
||||
DUPILUMAB, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 477 | 26881488 |
CA |
44 | 2 |
Liver injury, Anti-cyclic citrullinated peptide antibody positive, Helicobacter infection, Lung disorder, Musculoskeletal pain, Gait inability, Gastrointestinal disorder, Facet joint syndrome, Nasopharyngitis, Hypoaesthesia, Fatigue, Underdose, Muscle spasms, X-ray abnormal, Pain in extremity, Folliculitis, Drug hypersensitivity, Decreased appetite, Anxiety, Synovitis, Alopecia, Blister, C-reactive protein abnormal, C-reactive protein increased, Night sweats, Anti-cyclic citrullinated peptide antibody, Glossodynia, Lower limb fracture, Injury, Drug intolerance, Hand deformity, Confusional state, Fibromyalgia, Blood cholesterol increased, Musculoskeletal stiffness, Abdominal pain, Joint swelling, Lower respiratory tract infection, Impaired healing, Headache, Bone erosion, Oedema peripheral, Deep vein thrombosis postoperative, Hypersensitivity, Obesity, Asthenia, Muscle injury, Intentional product use issue, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ABATACEPT, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALENDRONATE SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PREDNISONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, APREMILAST, APREMILAST, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CERTOLIZUMAB PEGOL, VITAMIN C, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, APREPITANT, FOSAPREPITANT DIMEGLUMINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CELECOXIB, CELECOXIB, CELECOXIB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CALCIUM CARBONATE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, APREPITANT, APREPITANT, APREPITANT, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, PREGABALIN, PREGABALIN, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CELECOXIB, CELECOXIB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, APREMILAST, APREMILAST, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VEDOLIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 478 | 26881869 |
US |
69 | 1 |
Hypersensitivity, |
||||
VIBEGRON, |
||||
| 479 | 26881873 |
US |
||
Hypersensitivity, Product substitution issue, |
||||
TELMISARTAN, |
||||
| 480 | 26881917 |
US |
2 | |
Pulmonary oedema, Skin exfoliation, Skin swelling, Lymphadenopathy, Dermatitis atopic, Rash, Hypersensitivity, |
||||
DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLONAZEPAM, AMPHETAMINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, TIZANIDINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VORTIOXETINE, PYRITHIONE ZINC, ERGOCALCIFEROL, LIFITEGRAST, |
||||
| 481 | 26881933 |
US |
66 | 1 |
Hypersensitivity, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 482 | 26882036 |
US |
||
Hypersensitivity, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 483 | 26882445 |
CA |
41 | 2 |
Angioedema, Drug intolerance, Product ineffective for unapproved use, Hypersensitivity, Dysphonia, Swelling face, Drug ineffective, Headache, Off label use, Swollen tongue, |
||||
ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZITHROMYCIN MONOHYDRATE, BOTULINUM TOXIN TYPE A, CLARITHROMYCIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESCITALOPRAM OXALATE, ESCITALOPRAM, LANSOPRAZOLE, LANSOPRAZOLE, FLUCONAZOLE, MOMETASONE FUROATE, MOMETASONE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, RABEPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL, SERTRALINE HYDROCHLORIDE, SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TRIMETHOPRIM, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ZOLMITRIPTAN, RIZATRIPTAN BENZOATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, FLUTICASONE PROPIONATE, ALLOPURINOL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ACETAMINOPHEN AND CODEINE, CEFUROXIME AXETIL, SODIUM SULFATE ANHYDROUS, DULOXETINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, FLUOXETINE HYDROCHLORIDE, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE, LISINOPRIL, DANAZOL, MORPHINE SULFATE, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, |
||||
| 484 | 26883074 |
US |
29 | |
Rash, Lip swelling, Pruritus, Condition aggravated, Hypersensitivity, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 485 | 26883195 |
US |
72 | 2 |
Autoimmune disorder, Eczema, Rash macular, Hypersensitivity, |
||||
DUPILUMAB, TOCILIZUMAB, ROFLUMILAST, |
||||
| 486 | 26883403 |
PE |
26 | 2 |
Influenza, Malaise, Sneezing, Hypersensitivity, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 487 | 26883484 |
EU |
1 | |
Plasma cell myeloma, Hypersensitivity, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, |
||||
| 488 | 26883642 |
US |
76 | 2 |
Hypersensitivity, Lip swelling, Muscle disorder, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 489 | 26884157 |
US |
2 | |
Hypersensitivity, |
||||
INCLISIRAN, |
||||
| 490 | 26884244 |
US |
2 | |
Asthma, Hypersensitivity, Neck injury, Pain, |
||||
DUPILUMAB, |
||||
| 491 | 26884462 |
CA |
44 | 2 |
Liver injury, Nasopharyngitis, Hypoaesthesia, Folliculitis, Musculoskeletal stiffness, Facet joint syndrome, Glossodynia, Helicobacter infection, Drug hypersensitivity, Hand deformity, Gastrointestinal disorder, Fatigue, Musculoskeletal pain, Hypersensitivity, Gait inability, Headache, Lower limb fracture, Muscle injury, Muscle spasms, Lower respiratory tract infection, Decreased appetite, Deep vein thrombosis postoperative, Fibromyalgia, Lung disorder, Drug intolerance, Night sweats, Injury, Intentional product use issue, Impaired healing, Joint swelling, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 492 | 26884903 |
US |
34 | 2 |
Hypersensitivity, |
||||
NATALIZUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 493 | 26885118 |
US |
33 | 2 |
Hypersensitivity, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 494 | 26885128 |
US |
46 | |
Hypersensitivity, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MACITENTAN, |
||||
| 495 | 26885353 |
EU |
85 | 1 |
Arrhythmia, Weight decreased, Hypotension, Hypoacusis, Movement disorder, Sleep disorder, Weight increased, Rash pruritic, Electrolyte imbalance, Blood uric acid increased, Dehydration, Confusional state, Hypersensitivity, Hypoacusis, Tinnitus, Nausea, Diarrhoea, Dry mouth, Decreased appetite, Muscle spasms, Chills, Gout, Dizziness, Malaise, Hypoaesthesia, Muscular weakness, Constipation, |
||||
ROSUVASTATIN, FUROSEMIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SPIRONOLACTONE, FUROSEMIDE, |
||||
| 496 | 26885563 |
US |
1 | |
Headache, Fatigue, Hypersensitivity, Inappropriate schedule of product administration, Patient dissatisfaction with treatment, Circumstance or information capable of leading to medication error, Product complaint, Product knowledge deficit, |
||||
PERFLUOROHEXYLOCTANE, PERFLUOROHEXYLOCTANE, |
||||
| 497 | 26885632 |
US |
59 | |
Hypersensitivity, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 498 | 26885698 |
US |
17 | |
Hypersensitivity, |
||||
SMOFLIPID, |
||||
| 499 | 26885871 |
CA |
||
Abdominal pain upper, Hypersensitivity, Madarosis, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DEXLANSOPRAZOLE, PROGESTERONE, TITANIUM DIOXIDE, |
||||
| 500 | 26886171 |
US |
66 | 1 |
Hypersensitivity, |
||||
TOCILIZUMAB-AAZG, DIPHENHYDRAMINE HYDROCHLORIDE, RIVAROXABAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30